Back to search
Healthy Elderly Subjects
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Elderly Subjects trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Elderly Subjects trials you may qualify forRecent studies suggest B-vitamins such as riboflavin to possess prebiotic-like effects. However, there is still a lack of understanding of the exact host health…
All participants will undergo baseline biopsies of subcutaneous abdominal adipose tissue for cellular/molecular profiling via snRNA-seq and metabolic/physiologi…
Polyphenols, precisely resveratrol, with red wine as the most substantial source, was associated with improvements in cognitive function. Also, the loss of musc…
This is a randomized, double-blind, placebo-controlled, two-arm crossover clinical trial evaluating the effects of a patented age-reversal therapy, EGA®, compar…
Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerability.
This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intra…
This was a double blind, randomized, placebo controlled, single and multiple IV dose study conducted in 2 parts, single ascending dose and multiple ascending do…
A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.